Highlights Hologic, Inc.

Equities

HOLX

US4364401012

Real-time Estimate Cboe BZX Other stock markets 12:32:55 2024-05-17 pm EDT			5-day change	1st Jan Change
74.42 ^USD	-0.71%		-0.76%	+4.37%

May. 09	Argus Adjusts Price Target on Hologic to $95 From $89	MT
May. 06	Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	May. 05	MT
Hologic Fiscal Q2 Earnings, Revenue Decline; Q3 Outlook Issued, Fiscal 2024 Estimates Revised -- Shares Up After Hours	May. 02	MT
Earnings Flash (HOLX) HOLOGIC Posts Q2 EPS $1.03, vs. Street Est of $0.98	May. 02	MT
Earnings Flash (HOLX) HOLOGIC Reports Q2 Revenue $1.02B, vs. Street Est of $1B	May. 02	MT
(HOLX) HOLOGIC Expects Fiscal Year 2024 EPS Range $4.02 - $4.12	May. 02	MT
(HOLX) HOLOGIC Sees Q3 EPS Range $0.98 - $1.05	May. 02	MT
Hologic, Inc. Revises Earnings Guidance for the Fiscal Year 2024	May. 02	CI
Hologic, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2024	May. 02	CI
Hologic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 30, 2024	May. 02	CI
Molten Ventures portfolio firm gets bought by Hologic	Apr. 30	AN
Molten Ventures portfolio firm to buy Endomagnetics for USD310 million	Apr. 30	AN
Hologic to Acquire Breast Cancer Surgery Technology Firm Endomagnetics For $310 Million	Apr. 29	MT
Hologic, Inc. signed a definitive agreement to acquire Endomagnetics Ltd. for approximately $310 million.	Apr. 28	CI
Bayer and Hologic Collaborates to Deliver Contrast-Enhanced Mammography	Apr. 11	CI
Hologic, Inc. and Biotheranostics, Inc. Announces Newly Published Study Results Reveal That Use of the Breast Cancer Index®? Test	Mar. 05	CI
FDA warns of potential risk from Hologic's devices implanted in soft tissue	Feb. 27	RE
FDA warns of potential risk of complications with use of Hologic's devices	Feb. 27	RE
Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on September 23, 2022.	Feb. 02	CI
Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on November 9, 2023.	Feb. 02	CI
Hologic Gets FDA Clearance For Cancer-Cell Diagnostic System	Feb. 01	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hologic, Inc.

Equities

HOLX

US4364401012

Highlights

Filters